Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis
- 1 July 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (7) , 3138-3139
Abstract
New delivery vehicles and routes of delivery were developed for the capuramycin analogue SQ641. While this compound has remarkable in vitro potency against Mycobacterium tuberculosis , it has low solubility in water and poor intracellular activity. We demonstrate here that SQ641 dissolved in the water-soluble vitamin E analogue α-tocopheryl polyethylene glycol 1000 succinate (TPGS) or incorporated into TPGS-micelles has significant activity in a mouse model of tuberculosis.Keywords
This publication has 8 references indexed in Scilit:
- In Vitro Antimycobacterial Activities of Capuramycin AnaloguesAntimicrobial Agents and Chemotherapy, 2008
- Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB DrugsAntimicrobial Agents and Chemotherapy, 2007
- Rapid, Simple In Vivo Screen for New Drugs Active against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2004
- Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivoJournal of Antimicrobial Chemotherapy, 2004
- Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycinBioorganic & Medicinal Chemistry Letters, 2003
- Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesisNatural Product Reports, 2003
- Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in miceAntimicrobial Agents and Chemotherapy, 1992
- Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.The Journal of Antibiotics, 1986